Chhablani Jay, Sambhana Sarita, Mathai Annie, Gupta Vishali, Arevalo J Fernando, Kozak Igor
L V Prasad Eye Institute, Hyderabad, India.
King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Am J Ophthalmol. 2015 May;159(5):884-9. doi: 10.1016/j.ajo.2015.02.006. Epub 2015 Feb 19.
To compare the clinical efficacy of navigated pattern and conventional slit-lamp pattern panretinal photocoagulation (PRP).
Randomized clinical trial.
Seventy-four eyes with proliferative diabetic retinopathy (PDR) in need of PRP were randomly assigned to 1 of 4 groups: PRP conventional pattern 30 ms, 100 ms, navigated pattern 30 ms, 100 ms pulse. Navigated laser is a fundus camera-based photocoagulator with retinal eye tracking. Outcome variables included stability of visual acuity, regression or development of neovascularization and need for retreatment sessions and surgical intervention, pain perception, and procedure time.
There was no change in visual acuity between pre- and post-treatment measurements among the study groups. Short pulse groups in total required 22 procedures compared to 12 procedures in long pulse groups (P < .05). A trend toward worse outcome using 30 ms pulse duration treatments is expressed by slightly increased relative risk of 1.3 compared to 100 ms groups. Only 2 eyes required vitreoretinal surgery for nonclearing vitreous hemorrhage, 1 in each 30 ms group; insignificantly different between study groups (P = .98). The pain score was lower with navigated laser as compared to conventional laser in both 30 ms groups (P = .1) and 100 ms groups, where it reached statistical significance (P = .02). Pain experience was significant (P < .001) between navigated 100 ms pattern and conventional single-spot 100 ms treatments.
This study demonstrates better clinical efficacy of 100 ms compared to 30 ms treatments using both conventional and navigated pattern lasers. The ability to use long-pulse-duration navigated pattern treatments broadens therapeutic options for PRP in proliferative diabetic retinopathy.
比较导航模式与传统裂隙灯模式全视网膜光凝(PRP)的临床疗效。
随机临床试验。
74只需要进行PRP的增殖性糖尿病视网膜病变(PDR)患眼被随机分为4组中的1组:PRP传统模式30毫秒、100毫秒,导航模式30毫秒、100毫秒脉冲。导航激光是一种基于眼底相机的光凝器,具有视网膜眼跟踪功能。结果变量包括视力稳定性、新生血管的消退或进展以及再次治疗和手术干预的需求、疼痛感知和操作时间。
研究组治疗前后的视力没有变化。短脉冲组总共需要22次操作,而长脉冲组为12次操作(P <.05)。与100毫秒组相比,使用30毫秒脉冲持续时间治疗的结果有变差的趋势,相对风险略有增加,为1.3。只有2只眼因玻璃体积血不吸收需要进行玻璃体视网膜手术,每组30毫秒组各1只;研究组之间无显著差异(P =.98)。在30毫秒组(P =.1)和100毫秒组中,导航激光的疼痛评分均低于传统激光,在100毫秒组达到统计学意义(P =.02)。导航100毫秒模式与传统单点100毫秒治疗之间的疼痛体验有显著差异(P <.001)。
本研究表明,使用传统和导航模式激光治疗时,100毫秒治疗的临床疗效优于30毫秒治疗。使用长脉冲持续时间导航模式治疗的能力拓宽了增殖性糖尿病视网膜病变PRP的治疗选择。